Lonafarnib for Patients With Hutchinson-Gilford Progeria Syndrome or Progeroid Laminopathy

NCT03895528 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Progeria
HGPS

Interventions

DRUG: Lonafarnib

Sponsor

Eiger BioPharmaceuticals